Expedited Drug Analysis Program

This solicitation was for an Expedited Drug Analysis Program, aimed at providing rapid laboratory testing services for pharmaceutical substances. The work likely involves analytical chemistry, validation of drug products, and reporting of results within tight timelines to support public health or regulatory needs. • Scope: Fast turnaround drug testing, including sample receipt, analysis, and results delivery. • Delivery: Services to be performed by a qualified laboratory (National Medical Services) under a fixed‑price arrangement. • Timeline: Bids were due 19 Nov 2018; award was announced 10 Jan 2020, indicating a multi‑month evaluation period.